Brief: 2seventy bio Says Abecma Generated About $69 Mln In Q3 U.S. Revenue
26/10/2023 12:32
Oct 26 (Reuters) - 2Seventy Bio Inc TSVT.O :
* 2SEVENTY BIO INC - ABECMA (IDECABTAGENE VICLEUCEL, OR
IDE-CEL)
GENERATED APPROXIMATELY $69 MILLION IN U.S. REVENUE DURING Q3 OF
2023
* 2SEVENTY BIO INC - BELIEVES THAT COMPETITIVE DYNAMICS
IMPACTING
ABECMA WILL CONTINUE INTO Q4 OF 2023
Further company coverage: TSVT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on 2Seventy Bio
See all news2Seventy Bio Inc expected to post a loss of 17 cents a share - Earnings Preview
2Seventy Bio Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: 2Seventy Bio Q4 Basic EPS USD -0.37
2Seventy Bio Inc expected to post a loss of 26 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney